Nuveen LLC bought a new position in Mativ Holdings, Inc. (NYSE:MATV - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 179,958 shares of the company's stock, valued at approximately $1,121,000. Nuveen LLC owned about 0.33% of Mativ at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. D. E. Shaw & Co. Inc. boosted its holdings in shares of Mativ by 85.9% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 504,422 shares of the company's stock valued at $5,498,000 after buying an additional 233,125 shares during the period. Allspring Global Investments Holdings LLC raised its position in Mativ by 5.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 4,131,328 shares of the company's stock worth $25,986,000 after acquiring an additional 217,691 shares in the last quarter. XTX Topco Ltd bought a new stake in Mativ during the first quarter worth $1,073,000. Tudor Investment Corp ET AL acquired a new position in shares of Mativ in the fourth quarter valued at $1,864,000. Finally, Bridgeway Capital Management LLC increased its holdings in shares of Mativ by 39.2% in the fourth quarter. Bridgeway Capital Management LLC now owns 541,432 shares of the company's stock valued at $5,902,000 after purchasing an additional 152,383 shares during the last quarter. Institutional investors and hedge funds own 94.95% of the company's stock.
Mativ Stock Up 2.9%
MATV stock traded up $0.35 during mid-day trading on Friday, reaching $12.40. 530,564 shares of the company traded hands, compared to its average volume of 788,803. The firm's 50 day moving average price is $9.14 and its 200 day moving average price is $7.08. Mativ Holdings, Inc. has a fifty-two week low of $4.34 and a fifty-two week high of $19.96. The stock has a market cap of $677.91 million, a price-to-earnings ratio of -1.49 and a beta of 0.83. The company has a quick ratio of 1.21, a current ratio of 2.37 and a debt-to-equity ratio of 2.65.
Mativ (NYSE:MATV - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.18 by $0.15. Mativ had a negative net margin of 23.09% and a positive return on equity of 4.12%. The firm had revenue of $525.40 million for the quarter, compared to the consensus estimate of $505.00 million. As a group, equities research analysts predict that Mativ Holdings, Inc. will post 1.15 EPS for the current fiscal year.
Mativ Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 26th. Investors of record on Friday, August 29th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend is Friday, August 29th. Mativ's dividend payout ratio (DPR) is presently -4.79%.
Analyst Ratings Changes
Several equities analysts recently commented on MATV shares. Zacks Research upgraded shares of Mativ to a "strong-buy" rating in a research note on Monday, August 11th. Wall Street Zen raised shares of Mativ from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Strong Buy" and a consensus target price of $10.00.
Check Out Our Latest Analysis on Mativ
Mativ Profile
(
Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Recommended Stories

Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.